Thank you for those that participated in this year’s Summit. Please find links to the materials provided at the event above. We will see you at our third annual Digital Health Investor Summit in 2014!
Digital health is quickly becoming an established sector, yet there are still a lot of unknown factors that leave many investors unable to effectively analyze opportunities. The Fenwick Digital Health Investor Summit will bring together investors focused on the life sciences, device, healthcare, internet, software and consumer sectors for a one day program designed to accelerate their understanding of digital health and uncover information that is causing a lack of confidence in the sector, such as payment models and exit opportunities. Select entrepreneurs will be invited for presentation and networking opportunities.
8:00 am - Registration & Breakfast
9:00 am - Welcome & Keynote
9:30 am - Digital Health in 2013 and Beyond
10:15 am - Payment Models
11:00 am - Exit Opportunities
11:45 am - Startup Pitches
12:30 pm - Lunch
Michael Esquivel, Partner at Fenwick & West practice, focuses on strategic counseling to emerging and high-growth companies primarily in the digital/mobile health, consumer Internet, social networking, information technology and clean technologies. He has negotiated and structured a wide variety of corporate transactions including: seed and venture capital financings, initial public offerings, mergers and acquisitions, corporate reorganizations and debt financings. Michael's activity in the growing digital health and healthcare IT industries.
Amit Sinha is a Managing Director in the Healthcare and Mergers & Acquisitions groups at Goldman Sachs. Amit has over 13 years of healthcare industry experience working with biotechnology and medical device companies on corporate strategy, financial transactions, investments and operational improvements. He possesses deep M&A and corporate finance experience with approximately $40 billion in publicly announced, executed transactions. His corporate finance experience includes capital structure / capital allocation strategies and balance sheet management. Amit has specific expertise in all areas of M&A including valuation, deal negotiation and management of board discussions.
Malay Gandhi is the Chief Strategy Officer at Rock Health works with Rock Health startups to design sustainable business models and leads the earned income and proprietary research efforts at Rock Health. He previously worked at Deloitte Consulting, where he advised leading payers and global pharma companies on growth. Malay earned a Masters in Health Policy from the University of Pittsburgh and a B.S. from West Virginia University.
M. Bridget Duffy, M.D., is the Chief Medical Officer for Vocera. Prior to founding ExperiaHealth, Dr. Duffy served as chief experience officer of the Cleveland Clinic–the first senior position of its kind in the nation—leading the institution in establishing patient experience as its top strategic priority. She is a frequent speaker on the subject of why the patient experience matters and how it impacts clinical outcomes. Her work has earned her the Quantum Leap Award for taking the risk to spur internal change in her field and has led her to be featured in HealthLeaders magazine as one of "20 People Who Make Healthcare Better."
Lisa Kennedy, Ph.D. is Chief Marketing Officer for GE’s healthymagination initiative, a $6 billion commitment to improving quality, access, and affordability with the goal of revolutionizing the world’s healthcare. Her team also leads digital health incubation focusing on patient empowerment and ambient intelligence. Dr. Kennedy joined GE Healthcare as Chief Economist before becoming Global Head of Marketing Operations, GEHC, where she was an integral part of the team that created healthymagination.
Dana Mead is a Partner at Kleiner Perkins Caufield & Byers and works in the firm’s life sciences practice. He leverages experience accrued from his venture-funded, startup management roles and board participation to support entrepreneurs and innovators dedicated to making a real difference in the lives of millions suffering from life-limiting diseases. Dana serves on the boards of Apnicure, Awarepoint, Corventis, Inspire Medical Systems, Intersect ENT, Invuity, Pulmonx, Spiracur, Spinal Modulation, Teladoc and Voyage Medical.
Christiaan Vorkink is a Partner at True Ventures. Previously, he spent eight years working in and around early stage technology companies. His first foray into entrepreneurship came in elementary school when he and his best friend managed the largest downtown newspaper delivery service in the small town in New Hampshire where they grew up. Prior to joining True, Christiaan was a senior analyst in the venture capital research group at Cambridge Associates and worked in network development at BrightRoll, a True portfolio company.
Meg McCabe is the President of Wellness 2.0, one of Aetna’s emerging businesses with Healthagen, headed by Chuck Saunders. Most recently she was VP of Consumer Solutions and has been working on consumer strategy for Aetna since 2003, including the launching of a differentiated suite of care management solutions (Aetna Health Connections), Aetna’s first enterprise mobile app, an industry leading PHR, and social media capabilities. Meg has many connections with stints in corporate strategy at Tufts Health Plan, Boston-based Parthenon Group, and she’s a Phi Beta Kappa graduate of Wellesley College and has an MBA from the Tuck School at Dartmouth College.
Zina Moukheiber writes about the entrepreneurs and trends shaping digital health for Forbes. Recent stories include a profile of Epic Systems founder Judy Faulkner, new health IT billionaire Terry Ragon, and open source electronic health records. Zina initiated regular coverage of the biotech industry at Forbes, and wrote many of the early stories on genomics, personalized medicine and the automation of drug making.
Chamath Palihapitiya is the Founder and Managing Partner of The Social+Capital Partnership (Social Capital) – a venture capital fund based in Palo Alto, CA that incubates and invests in breakthrough companies in healthcare, education, financial services, mobile and enterprise software. Preceding his focus as an investor, Chamath was the longest tenured member of Facebook’s senior executive team and helped drive its ascension to one of the most important companies in the world. Prior to Facebook, Chamath had leading roles at The Mayfield Fund, AIM and ICQ and Winamp.
Wade Roush is the Chief Correspondent and Editor of Xconomy San Francisco. Wade is a veteran journalist with a focus on information technology. As a staffer with MIT’s Technology Review from 2001 to 2006, he served as senior editor, San Francisco bureau chief, and executive editor of TechnologyReview.com. He has a B.A. in the history of science from Harvard University and a PhD in the history and social study of science and technology from MIT. His work has appeared in Science, Technology Review, IEEE Spectrum, and Encyclopaedia Britannica, and he has been a guest commentator on CNN, CNBC, NECN, WGBH, NPR and PBS.
Aaron Stoertzs the Health Program Manager at Google. He works to make Googlers the happiest and healthiest workforce on the planet. He leads the Benefits Accelerator, a health innovation group in Google's People Operations, and is creating a new wellness data infrastructure to improve optimization of Google Health. Prior to joining Google, Aaron was a Technical Officer at the World Health Organization HQ in Geneva, Switzerland. He has a MS-Global Health from Duke University and spends as much time in the Sierras as time will allow.
Jack Young is the director of Qualcomm Life Fund. Jack heads up the $100M Qualcomm Life Fund (QLF) at Qualcomm Ventures, which was recently ranked as one of the most prolific venture investors in the digital health sector. His investment interests are focused in the areas of digital technologies and wireless health services and applications including: wellness and fitness, chronic disease management, aging in place, transitional care, clinical trials and telehealth/telemedicine. Jack currently serves as a board observer at QLF portfolio companies including Airstrip, AliveCor, ClearCare, goBalto and Telcare. In addition, he serves as a board observer at Jana, Modern Video, uCIRRUS, Validity and Visage Mobile.